Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("OBACH, Rosendo")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 7 of 7

  • Page / 1
Export

Selection :

  • and

In Vitro Metabolism of Irosustat, a Novel Steroid Sulfatase Inhibitor: Interspecies Comparison, Metabolite Identification, and Metabolic Enzyme IdentificationVENTURA, Veronica; SOLA, Josep; CELMA, Carles et al.Drug metabolism and disposition. 2011, Vol 39, Num 7, pp 1235-1246, issn 0090-9556, 12 p.Article

Phase I pharmacological and bioavailability study of oral Diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumorsGELDERBLOM, Hans; SALAZAR, Ramon; PRINCIPE, Paola et al.Clinical cancer research. 2003, Vol 9, Num 11, pp 4101-4107, issn 1078-0432, 7 p.Article

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumoursTROCONIZ, Inaki F; GARRIDO, Maria J; SEGURA, Cristina et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 6, pp 727-735, issn 0344-5704, 9 p.Article

Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiencyTOMLINSON, Brian; THOMAS, Neil G; LAN, Irene W et al.Clinical pharmacokinetics. 2006, Vol 45, Num 10, pp 1003-1011, issn 0312-5963, 9 p.Article

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotypeSPARREBOOM, Alex; GELDERBLOM, Hans; MARSH, Sharon et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 1, pp 38-44, issn 0009-9236, 7 p.Article

Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumorsTROCONIZ, Iñaki F; CENDROS, Josep-María; OBACH, Rosendo et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 2, pp 239-250, issn 0344-5704, 12 p.Article

Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects : Evidence for Injection Interval of Up to 2 MonthsTROCONIZ, Inaki F; CENDROS, Josep-Maria; PERAIRE, Concepcion et al.Clinical pharmacokinetics. 2009, Vol 48, Num 1, pp 51-62, issn 0312-5963, 12 p.Article

  • Page / 1